Early findings of RAMPART trial showed a positive trend in DFS among the high-risk population while the results and publication are still awaited ( 13 ).
← all excerpts
Navigating Recurrence in Clear Cell Renal Cell Carcinoma after Adjuvant Immunotherapy.
1
—
—